{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:54:38Z","timestamp":1780473278042,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011824","name":"European Academy of Allergy and Clinical Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016185","name":"Aimmune Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017255","name":"Allergy Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jaip.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T03:02:53Z","timestamp":1574046173000},"page":"2360-2369.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-Effectiveness Analysis"],"prefix":"10.1016","volume":"8","author":[{"given":"Marcus","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Rambasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dykewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.11.004_bib1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1081-1206(10)60266-9","article-title":"A\u00a0retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria","volume":"103","author":"Najib","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.anai.2011.06.008","article-title":"Utility of routine laboratory testing in management of chronic urticaria\/angioedema","volume":"107","author":"Tarbox","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaip.2019.11.004_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jval.2017.10.017","article-title":"A\u00a0framework for measuring low-value care","volume":"21","author":"Miller","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jaip.2019.11.004_bib6","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2018.2856","article-title":"Adding cost-effectiveness to define low-value care","volume":"319","author":"Pandya","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.11.004_bib7","doi-asserted-by":"crossref","first-page":"j570","DOI":"10.1136\/bmj.j570","article-title":"Eliminating waste in healthcare spending","volume":"356","author":"Chalkidou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2019.11.004_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.2012.362","article-title":"Eliminating waste in US health care","volume":"307","author":"Berwick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.11.004_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anai.2019.05.012","article-title":"A\u00a0primer on cost-effectiveness in the allergy clinic","volume":"123","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1067\/mjd.2001.116217","article-title":"Natural course of physical and chronic urticaria and angioedema in 220 patients","volume":"45","author":"Kozel","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.11.004_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1398-9995.2004.00473.x","article-title":"Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients","volume":"59","author":"Toubi","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.004_bib13","first-page":"1","article-title":"United States Life Tables, 2013","volume":"66","author":"Arias","year":"2017","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jaip.2019.11.004_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.134.12.1575","article-title":"The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema","volume":"134","author":"Kozel","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2019.11.004_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40273-015-0375-7","article-title":"EQ-5D utilities in chronic spontaneous\/idiopathic urticaria","volume":"34","author":"Hawe","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaip.2019.11.004_bib18","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2019.11.004_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00019053-199915040-00004","article-title":"Utility scores for chronic conditions in a community-dwelling population","volume":"15","author":"Mittmann","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaip.2019.11.004_bib22","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"QALYs in 2018\u2014advantages and concerns","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.11.004_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/027298902320556118","article-title":"Health economic evaluations: the special case of end-stage renal disease treatment","volume":"22","author":"Winkelmayer","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jaip.2019.11.004_bib24","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/all.13209","article-title":"The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU","volume":"72","author":"Maurer","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.004_bib26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2000.105706","article-title":"Chronic urticaria","volume":"105","author":"Greaves","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1590\/abd1806-4841.20165071","article-title":"Impact of chronic urticaria on the quality of life of patients followed up at a university hospital","volume":"91","author":"Dias","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaip.2019.11.004_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13601-016-0120-0","article-title":"Improvement of sleep in patients with chronic idiopathic\/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies","volume":"6","author":"Gimenez-Arnau","year":"2016","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2019.11.004_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.12659\/MSM.912362","article-title":"Higher levels of depression and anxiety in patients with chronic urticaria","volume":"25","author":"Tat","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaip.2019.11.004_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1684\/ejd.2018.3446","article-title":"The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study)","volume":"28","author":"Lacour","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2019.11.004_bib31","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2004.12.1126","article-title":"Laboratory diagnostics for hereditary angioedema: an economic, evidence-based standpoint","volume":"115","author":"Krishna","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib32","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.jaip.2019.04.031","article-title":"Cost-utility of routine testing in chronic urticaria\/angioedema: a cohort study","volume":"7","author":"Carrillo-Martin","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.11.004_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.anai.2012.02.018","article-title":"The role of autoimmune testing in chronic idiopathic urticaria","volume":"108","author":"Viswanathan","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.004_bib34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/jama.1980.03300420028020","article-title":"Laboratory tests in chronic urticaria","volume":"243","author":"Jacobson","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.11.004_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1067\/mjd.2003.142","article-title":"Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review","volume":"48","author":"Kozel","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.11.004_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.1990.tb01449.x","article-title":"Chronic urticaria and cancer: an epidemiological study of 1155 patients","volume":"123","author":"Lindelof","year":"1990","journal-title":"Br J Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819309389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819309389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:24:41Z","timestamp":1761974681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819309389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213219819309389"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.11.004","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-Effectiveness Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}